icoagulation for a minimum of 6 weeks should be continued.
Consensus statement.
12.1.3 For patients with SVT of the main saphenous
trunks we suggest against using prophylactic or

therapeutic dose low-molecular weight heparin
(LMWH) and nonsteroid anti-inï¬‚ammatory drugs
(NSAIDs). While both have been found to reduce
SVT pain and extension, they have failed to prevent
VTE